SEARCH

SEARCH BY CITATION

References

  • 1
    Davies MJ , Thomas AC . Plaque fissuring--the cause of acute myocardial infarction, sudden ischaemic death, and crescendo angina . Br Heart J 1985 ; 53 : 36373 .
  • 2
    Hamsten A . The hemostatic system and coronary heart disease . Thromb Res 1993 ; 70 : 138 .
  • 3
    Meade TW , Mellows S , Brozovic M , Miller GJ , Chakrabarti RR , North WR , Haines AP , Stirling Y , Imeson JD , Thompson SG . Haemostatic function and ischaemic heart disease: principal results of the Northwick Park Heart Study . Lancet 1986 ; 2 : 5337 .
  • 4
    Danesh J , Collins R , Appleby P , Peto R . Association of fibrinogen, C-reactive protein, albumin, or leukocyte count with coronary heart disease: meta-analyses of prospective studies . JAMA 1998 ; 279 : 147782 .
  • 5
    Danesh J , Lewington S , Thompson SG , Lowe GD , Collins R , Kostis JB , Wilson AC , Folsom AR , Wu K , Benderly M , Goldbourt U , Willeit J , Kiechl S , Yarnell JW , Sweetnam PM , Elwood PC , Cushman M , Psaty BM , Tracy RP , Tybjaerg-Hansen A , et al. Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis . JAMA 2005 ; 294 : 1799809 .
  • 6
    Thompson SG , Kienast J , Pyke SD , Haverkate F , van de Loo JC . Hemostatic factors and the risk of myocardial infarction or sudden death in patients with angina pectoris. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group . N Engl J Med 1995 ; 332 : 63541 .
  • 7
    Stec JJ , Silbershatz H , Tofler GH , Matheney TH , Sutherland P , Lipinska I , Massaro JM , Wilson PF , Muller JE , D’Agostino RB Sr . Association of fibrinogen with cardiovascular risk factors and cardiovascular disease in the Framingham Offspring Population . Circulation 2000 ; 102 : 16348 .
  • 8
    Meade TW , Ruddock V , Stirling Y , Chakrabarti R , Miller GJ . Fibrinolytic activity, clotting factors, and long-term incidence of ischaemic heart disease in the Northwick Park Heart Study . Lancet 1993 ; 342 : 10769 .
  • 9
    Hamsten A , de Faire U , Walldius G , Dahlen G , Szamosi A , Landou C , Blomback M , Wiman B . Plasminogen activator inhibitor in plasma: risk factor for recurrent myocardial infarction . Lancet 1987 ; 2 : 39 .
  • 10
    Durante-Mangoni E , Davies GJ , Ahmed N , Ruggiero G , Michaelides K . The prothrombin G20210A polymorphism in patients with myocardial infarction . Blood Coagul Fibrinolysis 2002 ; 13 : 6038 .
  • 11
    Doggen CJM , Manger Cats V , Bertina RM , Reitsma PH , Vandenbroucke JP , Rosendaal FR . A genetic propensity to high factor VII is not associated with the risk of myocardial infarction in men . Thromb Haemost 1998 ; 80 : 2815 .
  • 12
    van der Bom JG , De Maat MP , Bots ML , Haverkate F , de Jong PT , Hofman A , Kluft C , Grobbee DE . Elevated plasma fibrinogen: cause or consequence of cardiovascular disease? Arterioscler Thromb Vasc Biol 1998 ; 18 : 6215 .
  • 13
    Smiles AM , Jenny NS , Tang Z , Arnold A , Cushman M , Tracy RP . No association of plasma prothrombin concentration or the G20210A mutation with incident cardiovascular disease: results from the Cardiovascular Health Study . Thromb Haemost 2002 ; 87 : 61421 .
  • 14
    Doggen CJM , Bertina RM , Manger Cats V , Rosendaal FR . Fibrinogen polymorphisms are not associated with the risk of myocardial infarction . Br J Haematol 2000 ; 110 : 9358 .
  • 15
    Keavney B , Danesh J , Parish S , Palmer A , Clark S , Youngman L , Delepine M , Lathrop M , Peto R , Collins R . Fibrinogen and coronary heart disease: test of causality by ‘Mendelian randomization’ . Int J Epidemiol 2006 ; 35 : 93543 .
  • 16
    Davey Smith G , Ebrahim S . What can mendelian randomisation tell us about modifiable behavioural and environmental exposures? BMJ 2005 ; 330 : 10769 .
  • 17
    Burzotta F , Paciaroni K , De Stefano V , Crea F , Maseri A , Leone G , Andreotti F . G20210A prothrombin gene polymorphism and coronary ischaemic syndromes: a phenotype-specific meta-analysis of 12 034 subjects . Heart 2004 ; 90 : 826 .
  • 18
    Ye Z , Liu EH , Higgins JP , Keavney BD , Lowe GD , Collins R , Danesh J . Seven haemostatic gene polymorphisms in coronary disease: meta-analysis of 66,155 cases and 91,307 controls . Lancet 2006 ; 367 : 6518 .
  • 19
    Boekholdt SM , Bijsterveld NR , Moons AH , Levi M , Buller HR , Peters RJ . Genetic variation in coagulation and fibrinolytic proteins and their relation with acute myocardial infarction: a systematic review . Circulation 2001 ; 104 : 30638 .
  • 20
    Zee RY , Cook NR , Cheng S , Erlich HA , Lindpaintner K , Ridker PM . Multi-locus candidate gene polymorphisms and risk of myocardial infarction: a population-based, prospective genetic analysis . J Thromb Haemost 2006 ; 4 : 3418 .
  • 21
    Moss AJ , Goldstein RE , Marder VJ , Sparks CE , Oakes D , Greenberg H , Weiss HJ , Zareba W , Brown MW , Liang CS , Lichstein E , Little WC , Gillespie JA , Van Voorhees L , Krone RJ , Bodenheimer MM , Hochman J , Dwyer EM Jr , Arora R , Marcus FI , et al. Thrombogenic factors and recurrent coronary events . Circulation 1999 ; 99 : 251722 .
  • 22
    Wiman B , Andersson T , Hallqvist J , Reuterwall C , Ahlbom A , deFaire U . Plasma levels of tissue plasminogen activator/plasminogen activator inhibitor-1 complex and von Willebrand factor are significant risk markers for recurrent myocardial infarction in the Stockholm Heart Epidemiology Program (SHEEP) study . Arterioscler Thromb Vasc Biol 2000 ; 20 : 201923 .
  • 23
    Poort SR , Rosendaal FR , Reitsma PH , Bertina RM . A common genetic variation in the 3’-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increase in venous thrombosis . Blood 1996 ; 88 : 3698703 .
  • 24
    Green F , Hamsten A , Blomback M , Humphries S . The role of beta-fibrinogen genotype in determining plasma fibrinogen levels in young survivors of myocardial infarction and healthy controls from Sweden . Thromb Haemost 1993 ; 70 : 91520 .
  • 25
    Humphries SE , Cook M , Dubowitz M , Stirling Y , Meade TW . Role of genetic variation at the fibrinogen locus in determination of plasma fibrinogen concentrations . Lancet 1987 ; 1 : 14525 .
  • 26
    Wattanakit K , Folsom AR , Chambless LE , Nieto FJ . Risk factors for cardiovascular event recurrence in the Atherosclerosis Risk in Communities (ARIC) study . Am Heart J 2005 ; 149 : 60612 .
  • 27
    Doggen CJM , Manger Cats V , Bertina RM , Rosendaal FR . Interaction of coagulation defects and cardiovascular risk factors: increased risk of myocardial infarction associated with factor V Leiden or prothrombin 20210A . Circulation 1998 ; 97 : 103741 .
  • 28
    Middendorf K , Gohring P , Huehns TY , Seidel D , Steinbeck G , Nikol S . Prevalence of resistance against activated protein C resulting from factor V Leiden is significantly increased in myocardial infarction: investigation of 507 patients with myocardial infarction . Am Heart J 2004 ; 147 : 897904 .
  • 29
    Iacoviello L , Di Castelnuovo A , De Knijff P , D’Orazio A , Amore C , Arboretti R , Kluft C , Benedetta DM . Polymorphisms in the coagulation factor VII gene and the risk of myocardial infarction . N Engl J Med 1998 ; 338 : 7985 .
  • 30
    Girelli D , Russo C , Ferraresi P , Olivieri O , Pinotti M , Friso S , Manzato F , Mazzucco A , Bernardi F , Corrocher R . Polymorphisms in the factor VII gene and the risk of myocardial infarction in patients with coronary artery disease . N Engl J Med 2000 ; 343 : 77480 .
  • 31
    Iwai N , Shimoike H , Nakamura Y , Tamaki S , Kinoshita M . The 4G/5G polymorphism of the plasminogen activator inhibitor gene is associated with the time course of progression to acute coronary syndromes . Atherosclerosis 1998 ; 136 : 10914 .
  • 32
    Mikkelsson J , Perola M , Wartiovaara U , Peltonen L , Palotie A , Penttila A , Karhunen PJ . Plasminogen activator inhibitor-1 (PAI-1) 4G/5G polymorphism, coronary thrombosis, and myocardial infarction in middle-aged Finnish men who died suddenly . Thromb Haemost 2000 ; 84 : 7882 .
  • 33
    Moss AJ , Ryan D , Oakes D , Goldstein RE , Greenberg H , Bodenheimer MM , Brown MW , Case RB , Dwyer EM Jr , Eberly SW , Francis CW , Gillespie JA , Krone RJ , Lichstein E , MacCluer JW , Marcus FI , McCarthy J , Sparks CE , Zareba W . Atherosclerotic risk genotypes and recurrent coronary events after myocardial infarction . Am J Cardiol 2005 ; 96 : 17782 .
  • 34
    Burzotta F , Leone AM , Paciaroni K , De Stefano V , Rossi E , Testa L , Giannico F , Leone G , Maseri A , Crea F , Andreotti F . G20210A prothrombin gene variant and clinical outcome in patients with a first acute coronary syndrome . Haematologica 2004 ; 89 : 11348 .
  • 35
    Rothberg MB , Celestin C , Fiore LD , Lawler E , Cook JR . Warfarin plus aspirin after myocardial infarction or the acute coronary syndrome: meta-analysis with estimates of risk and benefit . Ann Intern Med 2005 ; 143 : 24150 .